Citadel Advisors - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$3,447,745
+8.5%
191,968
+22.9%
0.00%0.0%
Q2 2023$3,177,697
+80.5%
156,229
+93.1%
0.00%
Q1 2023$1,760,797
-79.9%
80,919
-71.4%
0.00%
-100.0%
Q4 2022$8,768,372
-27.1%
282,942
-40.0%
0.00%
-33.3%
Q3 2022$12,028,000
+230.1%
471,478
+162.7%
0.00%
+200.0%
Q2 2022$3,644,000
+702.6%
179,475
+879.9%
0.00%
Q1 2022$454,000
+67.5%
18,316
+134.8%
0.00%
Q4 2021$271,000
+3.0%
7,800
-19.6%
0.00%
Q3 2021$263,000
-67.0%
9,700
-68.4%
0.00%
Q2 2021$796,000
-61.8%
30,700
-68.3%
0.00%
Q1 2021$2,084,000
-88.0%
96,731
-88.0%
0.00%
-100.0%
Q4 2020$17,377,000
+23.4%
808,244
-15.3%
0.01%
+25.0%
Q3 2020$14,077,000
-35.0%
954,362
-1.5%
0.00%
-50.0%
Q2 2020$21,644,000
+265.0%
968,830
+130.9%
0.01%
+166.7%
Q1 2020$5,930,000
+154.9%
419,679
+193.1%
0.00%
+200.0%
Q4 2019$2,326,000
-85.0%
143,162
-67.7%
0.00%
-87.5%
Q3 2019$15,492,000
-53.2%
442,756
-24.5%
0.01%
-46.7%
Q2 2019$33,091,000
-14.6%
586,524
+10.6%
0.02%
-21.1%
Q1 2019$38,751,000
+22.7%
530,467
+7.1%
0.02%
+11.8%
Q4 2018$31,592,000
-64.1%
495,265
-43.9%
0.02%
-57.5%
Q3 2018$88,043,000
+42.9%
882,460
+1.7%
0.04%
+29.0%
Q2 2018$61,627,000
+53.5%
867,498
+124.9%
0.03%
+47.6%
Q1 2018$40,150,000
-21.0%
385,767
-23.5%
0.02%
-30.0%
Q4 2017$50,820,000
+149.0%
504,569
-13.6%
0.03%
+87.5%
Q3 2017$20,406,000583,8490.02%
Other shareholders
ANAPTYSBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$65,033,00013.01%
EcoR1 Capital, LLC 7,521,024$186,070,0005.82%
GREAT POINT PARTNERS LLC 700,000$17,318,0004.18%
Frazier Life Sciences Management, L.P. 899,700$22,259,0001.90%
Boxer Capital, LLC 1,300,000$32,162,0001.65%
Logos Global Management LP 300,000$7,422,0000.96%
Deep Track Capital, LP 558,782$13,824,0000.89%
Palo Alto Investors LP 431,024$10,664,0000.82%
TCG Crossover Management, LLC 58,515$1,448,0000.58%
Rock Springs Capital Management LP 563,300$13,936,0000.35%
View complete list of ANAPTYSBIO INC shareholders